Tag: Direct-acting antivirals


  • DAA Therapy and HCC Risk in HIV-HCV Coinfection: Decline Over Time

    DAA Therapy and HCC Risk in HIV-HCV Coinfection: Decline Over Time

    Overview: HIV, HCV, and the risk of hepatocellular carcinoma Hepatocellular carcinoma (HCC) remains a major concern for people living with HIV who have a history of hepatitis C virus (HCV) infection. Even after successful HCV cure with direct-acting antivirals (DAAs), researchers have observed that the risk of developing HCC does not disappear entirely. This evolving…

  • DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection

    DAA Therapy Linked to Falling HCC Risk in HIV-HCV Coinfection

    Hepatitis C, HIV, and the evolving role of DAAs Direct-acting antivirals (DAAs) have transformed hepatitis C virus (HCV) treatment, offering cure rates that were once unimaginable. For people living with both HIV and HCV, the landscape has been more complex. While DAAs effectively clear the hepatitis C infection, experts have long asked how this virologic…

  • Global Progress Toward WHO 2030 Hepatitis C Elimination Targets

    Global Progress Toward WHO 2030 Hepatitis C Elimination Targets

    Global strides and remaining gaps in hepatitis C elimination New research offers a detailed, data-driven view of how the world is advancing toward the World Health Organization’s (WHO) 2030 hepatitis C elimination targets. While there are notable gains in some regions, persistent gaps in reducing new infections (incidence) and deaths (mortality) underscore the complexity of…

  • Global progress toward WHO 2030 hepatitis C elimination targets

    Global progress toward WHO 2030 hepatitis C elimination targets

    Global progress toward WHO 2030 hepatitis C elimination targets New research offers a measurable snapshot of how the world is tracking against the World Health Organization’s (WHO) ambitious 2030 goal to eliminate hepatitis C virus (HCV) as a public health threat. While the latest data signal meaningful strides in some regions, they also reveal persistent…

  • Scotland Nears WHO Target as Hepatitis C Incidence Falls Among PWID

    Scotland Nears WHO Target as Hepatitis C Incidence Falls Among PWID

    Scotland Nears WHO Target for Hepatitis C Elimination Scotland is edging closer to the World Health Organization’s hepatitis C virus (HCV) elimination target as a new modelling study reveals a significant drop in HCV incidence among people who inject drugs (PWID). The findings, drawn from one of the largest long-term cohorts of PWID, underscore the…